CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

Jan. 4—If you're looking for activities to beat the winter blues, look no further than the Washington Carnegie Public Library. From all you could ever want to know about the upcoming solar eclipse to ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

Join 19 News for extensive coverage of the 2024 Total Solar Eclipse starting on Monday, April 8, with 19 News at Noon. 19 News will be live with LIGHTS OUT IN THE LAND coverage from locations all over ...

Vir Biotechnology, Inc.'s phase 3 ECLIPSE program for HDV, leveraging tobevibart and elebsiran, shows promise based on positive phase 2 SOLSTICE study results. The global hepatitis D market size is ...

ECLIPSE ABOUT WHAT SCIENTISTS ARE LOOKING FORWARD TO. WE ARE JUST DAYS AWAY FROM A RARE CELESTIAL EVENT A TOTAL ECLIPSE OF THE SUN ON APRIL 8TH. MORE THAN 31 MILLION PEOPLE WILL BE IN THE PATH OF ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

An annular solar eclipse will make its appearance in the skies over North, Central and South America on October 14, creating a singular spectacle for those in its path — and a rare opportunity for ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

The Eclipse Foundation, best known for its Eclipse IDE, is moving into funding its open source projects via donations. Previously, all Eclipse development was done by individuals and organizations ...